The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Preliminary results from a pooled analysis of two phase I studies.
 
Ying Yuan
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Yongdong Jin
No Relationships to Disclose
 
Yueyin Pan
No Relationships to Disclose
 
Cunji Wang
No Relationships to Disclose
 
Zhiwu Wang
No Relationships to Disclose
 
Zhiye Zhang
No Relationships to Disclose
 
Xiangjiao Meng
No Relationships to Disclose
 
Yi Hu
No Relationships to Disclose
 
Mingfang Zhao
No Relationships to Disclose
 
Huijuan Wang
No Relationships to Disclose
 
Nong Yang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma
 
Dongde Wu
No Relationships to Disclose
 
Xiaorong Dong
No Relationships to Disclose
 
Dingzhi Huang
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Lian Liu
No Relationships to Disclose
 
Dong Hua
No Relationships to Disclose
 
Zengqing Guo
No Relationships to Disclose
 
Ke-Feng Ding
No Relationships to Disclose